Related Experiment Videos
Laser revascularisation
1Department of Cardiology, Papworth Hospital, Cambridge, UK.
Insights
Transmyocardial laser revascularization improves angina symptoms and exercise capacity in patients with coronary artery disease. Percutaneous myocardial laser revascularization offers similar benefits with a better safety profile.
Area of Science:
- Cardiology
- Minimally Invasive Surgery
Background:
- Coronary artery disease (CAD) refractory to medical therapy poses a clinical challenge.
- Patients with CAD not amenable to conventional revascularization require alternative treatments.
- Laser revascularization techniques aim to improve myocardial perfusion in these patients.
Purpose of the Study:
- To evaluate the efficacy and safety of transmyocardial laser revascularization (TMLR) in patients with refractory angina.
- To assess the outcomes of percutaneous myocardial laser revascularization (PMLR) as a less invasive alternative.
Main Methods:
- Surgical TMLR involves creating channels in the myocardium using a laser.
- Catheter-based PMLR utilizes laser energy delivered percutaneously.
- Patient outcomes including symptomatic improvement and exercise capacity were assessed.
Main Results:
- TMLR generally shows good symptomatic improvement in angina and increased exercise capacity.
- TMLR is associated with significant procedural morbidity and mortality.
- PMLR demonstrates improvement in angina symptoms and exercise capacity.
- PMLR exhibits a more favorable procedural risk profile compared to TMLR.
Conclusions:
- Both TMLR and PMLR can improve symptoms and exercise capacity in patients with refractory CAD.
- PMLR represents a promising, less invasive option with a better safety profile for myocardial revascularization.
Abstract:
Patients who present with angina pectoris due to underlying coronary artery disease which is not controlled by medical therapy, and who have disease which is not amenable to conventional forms of revascularisation, present an increasing clinical problem. Laser techniques have been introduced to improve myocardial perfusion in this group of patients. The surgical technique of transmyocardial laser revascularisation has been evaluated in this patient population. Generally, there has been a good symptomatic response in terms of improvement in angina, and in some studies an increase in exercise capacity. The technique, however, does carry significant morbidity and mortality. More recently, a catheter-based technique has been introduced--percutaneous myocardial laser revascularisation. This technique seems to improve symptoms of angina, produce an increase in exercise capacity, with a much more favourable procedural risk profile.